Crohn’s disease-related anal fistula cancer diagnosed by examination under anesthesia: a case report
Surgical Case Reports volume 9, Article number: 149 (2023)
As the number of patients with inflammatory bowel disease (IBD) increases, the incidence of IBD-related colorectal cancer (CRC) is also on the rise. Crohn’s disease (CD)-related CRC has been reported to have a poorer prognosis than sporadic CRC, and the early detection of CD-related CRC is difficult. Japanese patients with CD are reported to have a higher frequency of anorectal cancer than the Western population; however, methods for early diagnosis have not yet been established because of perianal pain during the examination.
We report a case of CD-related anal fistula cancer that was detected early by surveillance examination under anesthesia (EUA). The patient was a 37-year-old man, diagnosed with CD at the age of 15 years and started medical treatment. However, due to poor disease control, the intestinal tract remained highly inflamed and the patient continued to have over 10 bowel movements per day. He was referred to our hospital for surgical treatment after a colonoscopy (CS), which revealed multiple active ulcers and stenoses. Since three perianal seton drainage tubes had been placed around his anus since the age of 33 years, we decided to perform an EUA to rule out cancer coexistence in the anorectal region. After a random biopsy of the rectum by CS under general anesthesia, we resected and curetted multiple perianal fistulas as much as possible and reinserted the seton drainage tubes. Pathological examination of the fistula tract revealed adenocarcinoma in one tract, indicating the coexistence of anal fistula cancer. Based on the diagnosis of multiple intestinal stenoses and anal fistula cancer due to CD, we performed hand-assisted laparoscopic total colectomy, rectal amputation, extensive perineal resection, and reconstruction using a left rectus abdominis flap.
In a long-term CD patient with anorectal lesions, we performed an EUA to diagnose the coexistence of anal fistula cancer at an early stage, and surgical resection was achieved. EUA is effective for the early detection and treatment of CD-related CRC and may contribute to an improved prognosis.
The number of patients with Crohn’s disease (CD) has increased in recent years. With advances in medical treatment, the prognosis is relatively good, with a cumulative survival rate of 96.9% at 10 years after diagnosis .
However, digestive cancer complications are the main cause of the excess mortality associated with CD. In CD patients, the standardized mortality ratio for all causes and CD-specific causes is high, especially for small intestine and colorectal cancers (CRCs) .
The 5-year survival rates for CD complicated by malignancy have been reported as follows: Stage I (88%), Stage II (68%), Stage IIIa (71%), Stage IIIb (25%), and Stage IV (0%) .
CD complicated by advanced cancer has a poor prognosis, and early detection is critical. However, because of intractable anal lesions and intestinal stenosis, imaging evaluation is tough, making early detection difficult. Colonoscopy (CS) is often difficult to perform because of stenosis, and capsule endoscopy is not commonly performed.
In this report, we describe a case of CD-related anal fistula cancer that was diagnosed early through surveillance, and surgical resection was performed.
The patient was a 37-year-old man. He was diagnosed with CD at the age of 14 years. He was started on infliximab at age 26 years, followed by azathioprine at age 31 years, and budesonide at age 33 years, but his disease remained poorly controlled.
At the age of 35 years, he underwent seton drainage for his anal lesions and subsequently switched from infliximab to adalimumab, but the inflammation of the intestinal tract remained completely uncontrolled. At the age of 37 years, he was referred to our department for the surgical treatment of multiple stenoses of the intestinal tract and anorectal area.
He had no medical history, was 164.9 cm tall, weighed 47.8 kg, and had a body mass index of 17.6.
Physical examination revealed no tenderness in the abdomen, but he had 10 bowel movements per day, and 3 seton drainage tubes were placed around the anus. Outpatient rectal examination could not be performed due to pain. Blood test results showed anemia (Hb: 8.6 mg/dL) and low nutrition (albumin: 2.5 g/dL, prealbumin: 15 mg/dL); inflammatory markers were mildly elevated (CRP: 3.54 mg/dL).
CS showed a cobblestone appearance, a longitudinal ulcer, and multiple stenoses that were difficult to pass without a transnasal endoscope (Fig. 1a, b). Endoscopic contrast examination revealed severe stenosis in the transverse colon and rectum (Fig. 1c, d), which was considered an indication for surgery. The Montreal classification was A1L3B2p, and the CDAI was 283.
Prior to surgery, we decided to perform an examination under anesthesia (EUA) to exclude perianal malignancy. Rectal examination under general anesthesia reveals the anal fistula has one primary lesion and three secondary ones. One seton drainage tube was placed between the primary and secondary, and two seton drainage tubes were placed between the secondary lesions (Fig. 2a). Following this, endoscopy was performed, and a random biopsy was obtained from the stenosis of the rectum, which was difficult to evaluate in detail during the preoperative examination. The perianal infected foci were scraped, and the fistula tract was resected as far as possible and subjected to pathological examination. The operation was terminated by the reinsertion of a seton drainage tube (Fig. 2b).
Pathological examination revealed no malignancy in the random biopsy of the rectum, but part of the resected fistula revealed a highly differentiated adenocarcinoma, and the patient was proven to have coexisting anal fistula cancer (Fig. 2c, d).
Contrast-enhanced CT and contrast-enhanced magnetic resonance imaging studies were performed, but the perianal area showed severe inflammatory changes, and the spread of the lesion could not be evaluated. No obvious lymph node or distant metastasis was observed. Tumor markers (CEA: < 1.7 ng/mL, CA19-9 < 2 U/mL) were within the normal range.
Finally, we diagnosed the patient with CD-related anal fistula cancer (cT1N0M0 cStage I) and performed hand-assisted laparoscopic total colectomy, rectal amputation, extensive perineal resection, and reconstruction with a left rectus abdominis flap.
After total colectomy and partial rectal resection with hand-assisted laparoscopy, the patient underwent a transanal procedure. We performed a resection of the remaining rectum and an extensive perineal resection to remove the fistula as much as possible (Fig. 3a, b). The perineal tissue defect was replaced with a left rectus abdominis flap (Fig. 3c), and the remaining skin defect on the left buttock was treated with a segmental skin graft (Fig. 4c). The operative time was 12 h and 5 min, and the blood loss was 1280 mL. A urethral injury was found on postoperative day 14, but the patient recovered conservatively with the insertion of the urethral catheter. On postoperative day 44, the patient was discharged home.
Although the skin graft fell off, the skin flap survived, and epithelialization was achieved in most of the wound area 3 months postoperatively (Fig. 4d).
Pathological examination showed that the anal fistula cancer extended 4 cm in length, with a histology of well- or moderately differentiated tubular adenocarcinoma and mucinous adenocarcinoma. The pathological diagnosis was pT2N0M0 pStageIIA (UICC-TNM classification, 8th edition).
10 months postoperatively, the patient has had no apparent recurrence.
In Europe and the United States, meta-analyses have shown that patients with CD with widespread bowel inflammation are at high risk for developing CRC as well as ulcerative colitis (UC) [4, 5], and CD-related CRCs are reported to have poorer prognosis than UC-related CRCs . While right-sided colon cancer is reported to be more common in Europe and the United States [7, 8], anorectal cancer, including anal fistula, is more common in Japan. CD-related cancers in Japan occur most frequently in the anorectal region, including anal fistula cancer, which accounts for 51% of all cases, followed by rectal cancer (29%) . However, perianal examination of CD patients is often difficult because of pain and bowel stricture, and EUA with rectal examination and biopsy of the lesion has been proposed as a surveillance method.
CD-related colorectal cancer in Japan is characterized by (a) cancer onset at a young age (around 50 years old), (b) a long disease duration of more than 10 years, (c) invasive types (types 3, 4, or 5), (d) a tendency for poorly differentiated types (mucous carcinoma, poorly differentiated carcinoma), and (e) a predilection for the anorectal area . Based on these characteristics, it has been proposed that patients with the disease for at least 10 years undergo surveillance examinations every 12–24 months. In cases where cancer complications are suspected, repeated examinations over a shorter period may be considered.
Only nine cases of surgical resection of CD-related anorectal cancer have been reported in the English literature (Table 1) [10,11,12,13,14,15,16,17,18]. In addition, six cases of surgical resection of CD-related anorectal cancer diagnosed by EUA have been reported in the Japanese literature. In all of these cases, the disease duration was > 10 years, and abdominoperineal resection (APR) and total pelvic exenteration (TPE) were performed in most cases. Cancer surveillance revealed that the total detection rate of CRC was 6.19%, and the detection rate was 1.85% with core needle biopsy, 5.56% with endoscopic biopsy, and 5.88% with excisional biopsy .
At our institution, patients with CD who have had the disease for more than 10 years are actively screened for malignancy using EUA. We performed EUA in the lithotomy position under general anesthesia and CS after visual inspection and rectal examination. Because of rectal and anal stenosis, CS is frequently difficult, and we collaborate with and frequently perform procedures with endoscopists. In addition to the evaluation of stricture and biopsy of ulcerative lesions and fistulas, we performed random biopsies in the rectum and anal canal, even in the absence of obvious lesions. Finally, we resected the fistula as much as possible and submitted it to pathological examination to rule out the complication of anal fistula cancer. The surgery was concluded with the placement of seton drainage.
EUA is expected to be useful for the early detection and curative treatment of difficult-to-diagnose CD-related anorectal cancers. However, EUA has not been used in a long time, and there is a scarcity of data. Thus, it is necessary to examine the efficiency, usefulness, and medical economy of EUA by including more cases in the future.
Herein, we report a case of CD-related anal fistula cancer that was diagnosed early by the EUA.
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
Examination under anesthesia
Inflammatory bowel disease
Total pelvic exenteration
Iida M, Yao T, Okada M. Long-term follow-up study of Crohn’s disease in Japan. The research committee of inflammatory bowel disease in Japan. J Gastroenterol. 1995;30(Suppl 8):17–9.
Yasukawa S, Matsui T, Yano Y, Sato Y, Takada Y, Kishi M, et al. Crohn’s disease-specific mortality: a 30-year cohort study at a tertiary referral center in Japan. J Gastroenterol. 2019;54(1):42–52.
Higashi D, Katsuno H, Kimura H, Takahashi K, Ikeuchi H, Kono T, et al. Current state of and problems related to cancer of the intestinal tract associated with Crohn’s disease in Japan. Anticancer Res. 2016;36(7):3761–6.
Canavan C, Abrams KR, Mayberry JF. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther. 2006;23(8):1097–104.
Von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum. 2007;50(6):839–55.
Stahl TJ, Schoetz DJ, Roberts PL, Coller JA, Murray JJ, Silverman ML, et al. Crohn’s disease and carcinoma: increasing justification for surveillance? Dis Colon Rectum. 1992;35(9):850–6.
Noguchi T, Ishihara S, Uchino M, Ikeuchi H, Okabayashi K, Futami K, et al. Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease. J Gastroenterol. 2022;58(1):14–24.
Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, Loftus EV Jr. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4(3):335–42.
Hirano Y, Futami K, Higashi D, Mikami K, Maekawa T. Anorectal cancer surveillance in Crohn’s disease. J Anus Rectum Colon. 2018;2(4):145–54.
Devroe H, Coene L, Mortelmans LJ, Jutten G. Colloid carcinoma arising in an anorectal fistula in Crohn’s disease: a case report. Acta Chir Belg. 2005;105(1):110–1.
Tokunaga Y, Sasaki H, Saito T. Carcinoma in anorectal fistulas of Crohn’s disease with seton drainage. Case report and review of the literature. Digestion. 2008;77(1):20–1.
Bautista JM, Marín-Jiménez I, Moreno LH. A perianal mass in a Crohn’s disease patient. Gastroenterology. 2012;142(1):187.
Sogawa M, Watanabe K, Egashira Y, Maeda K, Morimoto K, Noguchi A, et al. Precise endoscopic and pathologic features in a Crohn’s disease case with two fistula-associated small bowel adenocarcinomas complicated by an anal canal adenocarcinoma. Intern Med. 2013;52(4):445–9.
Scharl M, Frei P, Frei SM, Biedermann L, Weber A, Rogler G. Epithelial-to-mesenchymal transition in a fistula-associated anal adenocarcinoma in a patient with long-standing Crohn’s disease. Eur J Gastroenterol Hepatol. 2014;26(1):114–8.
Maejima T, Kono T, Orii F, Maemoto A, Furukawa S, Liming W, et al. Anal canal adenocarcinoma in a patient with longstanding Crohn’s disease arising from rectal mucosa that migrated from a previously treated rectovaginal fistula. Am J Case Rep. 2016;4(17):448–53.
Pareja-López Á, Ferrer-Márquez M, Berenguel-Ibáñez MDM, Espínola-Cortés N, Velasco-Albendea FJ. Perianal eccrine hydroadenocarcinoma in the context of a fistulising Crohn’s disease. Gastroenterol Hepatol. 2018;41(7):450–2.
Ehrl D, Rentsch M, Moellhoff N, Wachtel N. Complex microsurgical perineal reconstruction after resection of a giant verrucous carcinoma associated with anal fistulas in Crohn’s disease—a unique case report. Int J Colorectal Dis. 2020;35(7):1337–41.
Komono A, Yoshimatsu G, Kajitani R, Matsumoto Y, Aisu N, Hasegawa S. Reconstruction with omental flap and negative pressure wound therapy after total pelvic exenteration of anal fistula cancer: a case report. Surg Case Rep. 2022;8(1):116.
Matsuno H, Mizushima T, Nezu R, Nakajima K, Takahashi H, Haraguchi N, et al. Detection of anorectal cancer among patients with Crohn’s disease undergoing surveillance with various biopsy methods. Digestion. 2016;94(1):24–9.
This study was not funded.
Ethics approval and consent to participate
Written informed consent was received from the patient for publication of this case report and any accompanying images.
Consent for publication
Written informed consent was received from the patient for publication of this case report and any accompanying images.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kaneshiro, D., Sanechika, Y., Kishi, K. et al. Crohn’s disease-related anal fistula cancer diagnosed by examination under anesthesia: a case report. surg case rep 9, 149 (2023). https://doi.org/10.1186/s40792-023-01722-8